Heart Failure with Recovered Left Ventricle Ejection Fraction. Case Report
Insuficiencia cardíaca con fracción de eyección del ventrículo izquierdo recuperada. Reporte de caso | 左心室射血分数恢复的心力衰竭：病例报告
DOI:
https://doi.org/10.25176/RFMH.v24i3.6255Keywords:
Heart failure, pharmacotherapy, dilated cardiomyopathy, ventricular remodelingAbstract
Heart failure with recovered ejection fraction is defined as the improvement of left ventricular systolic function (LVEF) to values ≥ 40%, after having presented a reduced LVEF (< 40%) at a previous time and ≥10% absolute improvement in LVEF. It is a chronic and dynamic condition with a high risk of relapse and deterioration, so close monitoring and optimal medical therapy are essential for its management. A case is presented of a young male patient with dilated cardiomyopathy with severe left ventricular systolic dysfunction, who with neurohormonal therapy for heart failure, showed rapid clinical recovery and improvement of ejection fraction and left ventricular remodeling. Further studies are needed to better understand this condition and its long-term treatment.
Downloads
References
Wilcox JE, Fang JC, Margulies KB, Mann DL. Heart Failure With Recovered Left Ventricular Ejection Fraction: JACC Scientific Expert Panel. J Am Coll Cardiol. 2020 Aug 11;76(6):719-734. doi: 10.1016/j.jacc.2020.05.075.
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2023 Oct 1;44(37):3627-3639. doi: 10.1093/eurheartj/ehad195.
Maddox TM, Januzzi JL Jr, Allen LA, Breathett K, Butler J, Fonarow GC, et al. 2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2021 Feb 16;77(6):772-810. doi: 10.1016/j.jacc.2020.11.022
Merlo M, Cannatà A, Gobbo M, Stolfo D, Elliott PM, Sinagra G. Evolving concepts in dilated cardiomyopathy. Eur J Heart Fail. 2018 Feb;20(2):228-239. doi: 10.1002/ejhf.1103.
María Valverde-Gómez, Rafael Salguero-Bodes, Cristina Martín-Arriscado, Juan Delgado-Jiménez, Fernando Arribas-Ynsaurriaga, Julián Palomino-Doza. Miocardiopatía dilatada asociada a variantes tipo truncamiento en titina: no solo recuperación de la FEVI, también mantenimiento. Rev Esp Cardiol. 2020;73:589-92. doi: https://doi.org/10.1016/j.recesp.2019.12.024
Galve Basilio E, Alfonso Manterola F, Ballester Rodés M, Castro Beiras A, Fernández de Soria Pantoja R, Penas Lado M, Sánchez Domínguez J. Guías de práctica clínica de la Sociedad Española de Cardiología en miocardiopatías y miocarditis Rev Esp Cardiol. 2000 Mar;53(3):360-93. doi: 10.1016/s0300-8932(00)75104-9.
Wu KC, Weiss RG, Thiemann DR, Kitagawa K, Schmidt A, Dalal D, Lai S, Bluemke DA, Gerstenblith G, Marbán E, Tomaselli GF, Lima JA. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol. 2008 Jun 24;51(25):2414-21. doi: 10.1016/j.jacc.2008.03.018.
Mann DL, Barger PM, Burkhoff D. Myocardial recovery and the failing heart: myth, magic, or molecular target? J Am Coll Cardiol. 2012 Dec 18;60(24):2465-72. doi: 10.1016/j.jacc.2012.06.062.
Tanabe K, Sakamoto T. Heart failure with recovered ejection fraction. J Echocardiogr. 2019 Mar;17(1):5-9. doi: 10.1007/s12574-018-0396-2.
Zhang X, Sun Y, Zhang Y, Chen F, Dai M, Si J, Yang J, Li X, Li J, Xia Y, Tse G, Liu Y. Characteristics and outcomes of heart failure with recovered left ventricular ejection fraction. ESC Heart Fail. 2021 Dec;8(6):5383-5391. doi: 10.1002/ehf2.13630.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Revista de la Facultad de Medicina Humana
This work is licensed under a Creative Commons Attribution 4.0 International License.
